USA - NYSE:ITGR - US45826H1095 - Common Stock
The current stock price of ITGR is 68.13 USD. In the past month the price decreased by -7.8%. In the past year, price decreased by -50.67%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.84 | 215.76B | ||
| ISRG | INTUITIVE SURGICAL INC | 64.14 | 197.96B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.75 | 143.14B | ||
| SYK | STRYKER CORP | 27.37 | 137.82B | ||
| IDXX | IDEXX LABORATORIES INC | 54.67 | 55.15B | ||
| BDX | BECTON DICKINSON AND CO | 13.15 | 54.34B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.72 | 49.37B | ||
| RMD | RESMED INC | 24.64 | 35.60B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.29 | 34.13B | ||
| DXCM | DEXCOM INC | 31.41 | 22.91B | ||
| PODD | INSULET CORP | 68.47 | 22.02B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.01 | 17.64B |
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The company is headquartered in Plano, Texas and currently employs 11,000 full-time employees. The company went IPO on 2000-09-29. The firm serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
INTEGER HOLDINGS CORP
5830 Granite Parkway., Suite 1150
Plano TEXAS 75024 US
CEO: Joseph W. Dziedzic
Employees: 11000
Phone: 12146185243
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The company is headquartered in Plano, Texas and currently employs 11,000 full-time employees. The company went IPO on 2000-09-29. The firm serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
The current stock price of ITGR is 68.13 USD. The price increased by 0.69% in the last trading session.
ITGR does not pay a dividend.
ITGR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for INTEGER HOLDINGS CORP (ITGR) is 11.21. This is based on the reported non-GAAP earnings per share of 6.08 and the current share price of 68.13 USD.
The Revenue of INTEGER HOLDINGS CORP (ITGR) is expected to grow by 7.48% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
INTEGER HOLDINGS CORP (ITGR) has a market capitalization of 2.39B USD. This makes ITGR a Mid Cap stock.
ChartMill assigns a fundamental rating of 5 / 10 to ITGR. ITGR has only an average score on both its financial health and profitability.
Over the last trailing twelve months ITGR reported a non-GAAP Earnings per Share(EPS) of 6.08. The EPS increased by 15.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.75% | ||
| ROA | 2.56% | ||
| ROE | 4.98% | ||
| Debt/Equity | 0.7 |
17 analysts have analysed ITGR and the average price target is 95.3 USD. This implies a price increase of 39.88% is expected in the next year compared to the current price of 68.13.
For the next year, analysts expect an EPS growth of 21.97% and a revenue growth 7.48% for ITGR